Technology | Breast Biopsy Systems | July 24, 2019

Fujifilm Releases Tomosynthesis Biopsy Option for Aspire Cristalle Mammography System

Clinicians can use tomosynthesis guidance to calculate 3-D coordinates of suspicious breast lesion

Fujifilm Releases Tomosynthesis Biopsy Option for Aspire Cristalle Mammography System

July 24, 2019 – Fujifilm Medical Systems U.S.A. Inc. recently expanded its breast imaging solutions with the launch of its Tomosynthesis Biopsy option for the Aspire Cristalle mammography system. This new option uses tomosynthesis guidance to calculate 3-D coordinates of a suspicious lesion in the breast, in addition to the traditional stereotactic method. This allows radiologists to accurately complete biopsy of suspicious areas to conduct a pathological examination and inform the diagnosis and care plan. Clinicians will now be able to enhance diagnostic care for patients by using Tomosynthesis Biopsy to target a lesion previously undetectable on images from full field digital mammography (FFDM) alone.  

Clinicians can realize the following benefits when using the Tomosynthesis Biopsy in addition to Stereotactic Biopsy on the Aspire Cristalle with DBT mammography system:

  • Clinical Confidence: Clinicians will have more options to deliver enhanced diagnosis to patients. Now with Tomo Biopsy, targeting is improved by identifying the area of concern directly on the corresponding tomosynthesis slice;
  • Ease-of-Use: High-resolution dual display system, targeting guide function on stereo images, various image processing and other useful functions designed to make targeting accurate and easy; and
  • Increased Efficiency: Tomo Biopsy leads to a more efficient workflow with the potential to decrease exam times, as clinicians can use a single click to calculate 3-D coordinates compared to targeting the same lesion on two images with Stereotactic Biopsy. By using tomosynthesis images for targeting instead of traditional 2-D clinicians are also afforded the increased diagnostic confidence that comes hand-in-hand with tomosynthesis use.

The Fujifilm Aspire Cristalle with DBT combines state-of-the-art, Hexagonal Close Pattern (HCP) capture technology and intelligent image processing, optimizing dose and contrast based on individual breast composition. The result is low dose and fast acquisition of high-quality images for all breast types. In addition, patients can experience a noticeable improvement in comfort during procedures with Fujifilm’s patented, flexible comfort paddle design, which provides gentle and even compression that is designed to adapt to patient curves.

Fujifilm representatives are presenting Tomosynthesis Biopsy at Fujifilm’s booth at the Association for Medical Imaging Management (AHRA) annual meeting, July 21-24 in Denver.

For more information: www.fujifilmusa.com

Related Content

Screening Mammography Could Benefit Men at High Risk of Breast Cancer
News | Mammography | September 18, 2019
Selective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at...
The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology

The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology. Image courtesy of Siemens Healthineers.

Technology | Angiography | September 17, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of angiography systems...
3D Systems Earns Additional FDA Clearance for D2P Medical 3-D Printing Software

3D Systems’ D2P FDA-cleared software allows clinicians to 3-D-print diagnostic patient-specific anatomic models. Image courtesy of 3D Systems.

Technology | Medical 3-D Printing | September 12, 2019
3D Systems has received additional U.S. Food and Drug Administration (FDA) 510(k) clearance for its D2P software...
Richardson Healthcare Receives CE Mark Approval for ALTA750 Canon/Toshiba CT Replacement Tube
News | Computed Tomography (CT) | September 11, 2019
Richardson Healthcare, a Division of Richardson Electronics Ltd., announced it has received CE Mark approval for the...
Bayer Introduces Medrad Stellant Flex CT Injection System
Technology | Contrast Media Injectors | September 11, 2019
Bayer announced the introduction of the Medrad Stellant Flex computed tomography (CT) injection system. Stellant Flex...
iCAD's ProFound AI Wins Best New Radiology Solution in 2019 MedTech Breakthrough Awards
News | Computer-Aided Detection Software | September 09, 2019
iCAD Inc. announced MedTech Breakthrough, an independent organization that recognizes the top companies and solutions...
A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images

A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images. The algorithm, described at the SBI/ACR Breast Imaging Symposium, used deep learning, a form of machine learning, which is a type of artificial intelligence. Image courtesy of Sarah Eskreis-Winkler, M.D.

Feature | Society of Breast Imaging (SBI) | September 06, 2019 | By Greg Freiherr
The use of smart algorithms has the potential to make healthcare more efficient.
Sudhen Desai, M.D.

Sudhen Desai, M.D.

Feature | Pediatric Imaging | September 04, 2019 | By Jeff Zagoudis
Burnout has become a popular buzzword in today’s business world, meant to describe prolonged periods of stress in the
OSF HealthCare Expands Portfolio of Carestream Imaging Solutions
News | Digital Radiography (DR) | September 04, 2019
OSF HealthCare in Peoria, Ill., recently added a new Carestream DRX-Evolution Plus System to its portfolio of...
Global Diagnostics Australia Incorporates AI Into Radiology Applications
News | Artificial Intelligence | September 04, 2019
Global Diagnostics Australia (GDA), a subsidiary of the Integral Diagnostics Group (IDX), has adopted artificial...